A bstract. The Bio-Breeding/Worcester (BB/W) rat develops spontaneous autoimmune diabetes similar to human insulin-dependent diabetes mellitus. Transfusions of whole blood from the nondiabetic W-line of BB/W rats prevent the syndrome in diabetes-prone recipients. We report three experiments designed to determine which blood component is protective. In all experiments, diabetes-prone BB/W rats 23 to 35 d of age were given four or six weekly intravenous injections. In the first experiment, animals received either saline or transfusions of erythrocytes, white blood cells, or plasma from W-line donors. Diabetes occurred in 7/22 (32%) erythrocyte, 2/27 (7%) white cell, 14/24 (58%) plasma, and 15/27 (56%) saline recipients (P < 0.001). At 120 d of age, peripheral blood was obtained from nondiabetic rats. Fluorescence-activated cell sorter analysis of OX 19 tagged leucocytes revealed 35% T lymphocytes in white cell recipients (n = 13), compared with 9% in saline recipients (n = 7; P < 0.001). Responsiveness to concanavalin A was also increased in the white cell group, whereas the frequency of both insulitis and thyroiditis was decreased. In the second experiment, 1/19 (5%) rats transfused with W-line spleen cells developed diabetes, as contrasted with 12/18 (67%) recipients of diabetesprone spleen cells and 19/31 (61%) noninjected controls (P < 0.001). In the third experiment, diabetes-prone rats A preliminary account of this work has been presented in abstract form (Mordes, J. P., B. A. Woda, A. A. Like, D. Faustman, and A. A. Rossini. 1983. Lymphocyte transfusions prevent diabetes in Bio-Breeding/ Worcester rats. Diabetologia. 25:182.) 
Introduction
The Bio-Breeding (BB)' rat spontaneously develops a heritable syndrome that closely resembles human insulin-dependent diabetes mellitus (IDDM) (1) . The onset is abrupt. Untreated rats are hyperglycemic and ketonemic, and diabetic animals require insulin for survival. Genetic studies suggest that the disease is inherited as an autosomal recessive with incomplete penetrance (2) . Three separate genes may be involved (3) .
In the partially inbred Bio-Breeding/Worcester (BB/W) colony at the University of Massachusetts (Worcester), 40 to 60% of diabetes-prone animals become diabetic (4) , usually between 60 and 120 d of age. The rats are lean, and both sexes are equally affected. The physiologic derangements seen in diabetic animals are similar to those observed in human IDDM and include hypoinsulinemia and hyperglucagonemia. Histologic study of acutely diabetic animals reveals lymphocytic infiltration of the islets, or insulitis. Chronically diabetic animals have endstage islets, which are devoid of beta cells (4, 5) .
The observation of pancreatic insulitis suggests that BB rat diabetes has a cell-mediated immune pathogenesis. Additional data that support this concept include adoptive transfer of diabetes by means of concanavalin A (con A) stimulated lymphocytes (6) ; prevention by immunosuppressive agents, including antilymphocyte serum (7) , glucocorticoids (8) , cyclosporin-A (8, 9) , whole body irradiation (7) , and total lymphoid irradiation (10) ; and prevention by immune modulations, in-cluding neonatal thymectomy (I 1) and neonatal bone marrow allografts (12, 13) .
Transfusions ofwhole blood from nondiabetic rats also prevent diabetes in the BB/W rat (14) . The blood is obtained from the diabetes-resistant W-line of BB/W rats. Transfusion into young diabetes-prone BB/W rats prevents not only overt diabetes, but it also prevents insulitis and restores towards normal the depressed responsiveness of BB/W lymphocytes to the mitogen con A. The present studies were designed to determine which component of whole blood protects against diabetes in the BB/W rat.
Methods

Animals
All experiments used BB/W rats from the colony maintained at the University of Massachusetts. There are nine diabetes-prone and two diabetes-resistant lines of BB/W rats in this colony. Diabetes-prone transfusion recipients were drawn at random from the several lines being inbred. Male and female rats were used in approximately equal numbers.
Peripheral blood for transfusion was obtained exclusively from the diabetes-resistant W-line of BB/W rats. These animals were originally derived from diabetes-prone BB/W progenitors but have been bred for resistance to the disease. Through 11 generations of brother-sister mating (n > 1000), only three diabetic W-line rats have appeared. Splenic lymphocytes for transfusion were obtained either from W-line rats or from normoglycemic diabetes-prone BB/W rats drawn at random from the various family lines.
Preparation ofseparated blood components
Heparinized blood for transfusion was obtained by cardiac puncture and kept at room temperature. Hematocrit and white cell count were measured, and the pooled blood was centrifuged for 20 minutes at 2,000 g. The supernatant plasma was decanted and saved. The buffy coat, which contained residual plasma, and some ofthe uppermost erythrocytes were washed twice with 15 to 25 vol of 0.9% NaCl containing 0.2% dextrose and 0.15% Na2 EDTA and centrifuged at 500 g for 12 min. The supernatant containing most of the platelets was removed. The white cells were washed once more and then suspended in 0.9% NaCl and 0.2% dextrose.
To reduce white cell contamination, the packed erythrocyte concentrate was recombined with half the plasma and passed through a cellulose bed which contained equal amounts of microcrystalline cellulose (Sigmacell type 50) and a-cellulose (both from Sigma Chemical Co., St.
Louis, MO) (15 Preparation of T lymphocyte depleted whole blood Blood donors were W-line BB/W rats of both sexes and various ages. Whole blood was withdrawn from the periorbital sinus of ether anesthetized rats into heparinized glass capillary tubes. The blood was separated into two aliquots, one ofwhich was treated with a serum prepared against brain-associated T cell antigens (anti-BAT serum) and complement to deplete it of T cells.
Anti-BAT was a gift from Dr. M. Minami of Tokyo University. Anti-BAT serum is prepared in rabbits by immunization with rat whole brain tissue (16) . It cross reacts with theta 1 positive rat T cells (17) . The specific anti-BAT serum used in these studies was absorbed with mouse liver to remove class I and class II antibodies. After absorption, microcytotoxicity testing showed 50 to 60% splenocyte killing and 95% thymocyte killing. In further studies, rat whole blood was incubated with anti-BAT serum and R23 rabbit complement. After the erythrocytes were lysed with NH4CI, residual T lymphocyte activity was again measured by means of microcytotoxicity testing. The lymphocytes that had been treated with BAT serum demonstrated a kill rate of -20%, a rate indistinguishable from background. In contrast, lymphocytes from untreated blood demonstrated almost 100% killing. It has further been demonstrated that the BAT antibody is a pan-T cell antibody and that it is not cytotoxic in the absence of complement (J. Davie, personal communication).
The whole blood to be treated with anti-BAT serum was centrifuged at 500 g for 10 min and then washed twice with 250 ml RPMI. Each time, the supernatant was carefully removed with pipette suction to assure that the buffy coat was not disturbed.
For each 5.5 ml of packed blood cells, 220 lambda of anti-BAT serum was then added. The anti-BAT and blood cells were incubated for 30 min at room temperature. Every 15 s the cells were gently swirled.
The blood was then diluted with RPM! and centrifuged at 500 g for 10 min. As the supernatant was removed with a pipette, care was taken not to disturb the pellet. Next, 100 lambda of R23 rabbit complement was added to the pellet, which was then placed in a shaker bath at 370C for 30 min. During the incubation the tubes were swirled three additional times to ensure mixing. Finally, the cells were washed with RPMI and centrifuged at 500 g for 10 min. Control blood cells were processed identically, except that neither anti-BAT serum nor complement was added.
Lymphocyte subsets
Blood samples and spleens obtained from nondiabetic rats at the time of sacrifice were used to measure total peripheral white blood cell counts and peripheral and splenic lymphocyte subset percentages, as previously described (10, 18 
Con A stimulation
The response of lymphocytes to con A was measured as previously described (14) , using doses of 0.03, 0.125, 0.5 or 1.0 ,g/well. Measurements at each dosage were performed in triplicate and averaged.
Measurement of autoantibodies
Blood samples were obtained from animals at death. Details of the measurement procedure have previously been described (19) . The staining intensity of each sample was arbitrarily graded from 0 to 4+. Antibodies were considered to be present for any score of I or greater.
Histologic procedures
Pancreata and thyroids were fixed in Bouin's solution and embedded in paraffin. Sections were stained with hematoxylin and eosin and examined for the presence of insulitis (5) and thyroiditis (20) . The examinations were performed by a pathologist (Dr. Like) who was unaware of the treatment status of the rats.
Statistical procedures
Statistical analysis of 2 X 2 tables used the Fisher's exact test for n < 24; all other tables were analyzed by the chi square statistic with Yates' correction where appropriate (21) . Comparisons among three means used one-way analyses of variance; comparisons of two means used the unpaired t test with separate variance estimate (22) . For Between 113 and 134 d of age, four nondiabetic rats were selected daily at random from among the rats that had received either white cell concentrate or saline. Approximately 1 ml of blood was obtained from the tail vein and used to measure white blood cell count and the proportion of OX 19, W 3/25, and OX 8 positive peripheral blood lymphocytes. 13 white cell and 8 saline recipients were studied.
Also between 113 and 134 d of age, 39 rats were selected at random from the four experimental groups and used to measure con A-induced lymphocyte stimulation. After the rats were anesthetized with ether, 4 ml of blood was obtained from the orbital sinus. At least 7 d separated the two blood drawings in rats subjected to both procedures. One rat in the plasma group died of anesthesia before 120 d of age and has been omitted from all analyses.
All rats were sacrificed between 135 and 143 d of age. Whole blood was collected in plastic syringes by cardiac puncture and centrifuged. The serum was then frozen and used for the subsequent measurement of anti-smooth muscle and anti-thyroglobulin antibodies. The thyroids and pancreata were removed for later histologic study. The results of the second half of the experiment through 1 yr of age show a persistence of the trend observed for the whole group through 120 d of age. Diabetes has occurred in 2 of 12 (17%) white cell recipients, 5 of 9 (56%) erythrocyte recipients, 10 of 12 (83%) plasma recipients, and 10 of 13 (77%) saline recipients (chi square = 13.57, P < 0.005). Frequency of insulitis and thyroiditis. The frequencies of insulitis and thyroiditis for the 41 nondiabetic rats sacrificed in the first half of the experiment are shown in Table II . Only those rats given white blood cell concentrate were uniformly free of insulitis at the time of sacrifice. Both erythrocyte and white cell recipients had significantly less thyroiditis than did saline recipients. The white cell recipients also had less thyroiditis than did plasma recipients, but this difference was not statistically significant (P = 0.08).
Frequency ofdiabetes or insulitis considered together. When the animals in the first half of the experiment who had either insulitis or frank diabetes were grouped together, a dramatic effect of white cell transfusion and an intermediate effect of erythrocyte transfusion were again seen. None of the 15 white cell recipients developed either lesion, as contrasted with 4 of 13 (31%) erythrocyte recipients, 10 of 12 (83%) plasma recipients, and 8 of 14 (57%) saline controls (P < 0.001). Frequency ofautoantibodies. Autoantibodies were measured in the sera of the 41 nondiabetic rats sacrificed at 120 d of age. There was a significant reduction in the presence of anti-smooth muscle antibodies in the rats given white cell transfusions (1/15, 7%) compared with rats given plasma (4/6, 67%, P < 0.02) or saline (7/9, 78%, P < 0.005). In addition, there was a significant reduction in the occurrence of antibody in erythrocyte recipients (2/11, 18%, P < 0.02) compared with saline recipients. There were no statistically significant differences in the frequency of antithyroid colloid antibodies among the four groups. Antibodies were present in 3 of 15 (20%) white cell recipients, 3 of 11 (27%) erythrocyte recipients, 1 of 6 (17%) plasma recipients, and 5 of 9 (56%) saline recipients.
Con A induced lymphocyte stimulation. When cells were incubated in the absence of con A there were no significant differences in thymidine incorporation among the four groups of rats. At a dose of 0.03 ,ug per well, incorporation (loglocpm) was 5.42±0.08 in the erythrocyte group (n = 11) and 5.48±0.09 in the white cell group (n = 14). These results were similar and both were significantly higher (P < 0.05) than the incorporation in the plasma (4.93±0.25, n = 6) or saline (4.59±0.17, n = 8) groups. At a dose of 0.125 ,ug/well, the results were similar. The thymidine incorporation was 5.61±0.04 in the erythrocyte group and 5.56±0.05 in the white cell group. These results were both slightly but significantly (P < 0.05) greater than in the plasma (5.07±0.22) or saline (4.99±0.18) groups. At doses of 0.5 and 1.0 ,ug con A per well there were no significant differences in thymidine incorporation among the four groups.
Lymphocyte subsets. Peripheral blood lymphocyte subset percentages were measured in most of the nondiabetic white cell and saline treated rats between 113 and 134 d of age. The results are shown in Table III . They demonstrate a highly significant increase in total (OX 19 positive) T cells and in helper (W 3/25 positive) cells. The percentage ofsuppressor/killer (OX 8 positive) cells was also increased in the white cell recipients, but the increase was not statistically significant (P = 0.09).
Transfusion did not affect total white blood cell count. The subset percentages observed in the white cell recipients approach (P < 0.001) * P < 0.05 compared with T cell depleted blood group and P < 0.001 compared with saline.
i P < 0.001 compared with saline group. § P < 0.05 compared with saline group.
"P < 0.001 compared with saline group.
depleted blood or saline. The frequencies of diabetes in these last two groups were statistically similar. In contrast to the findings with regard to overt diabetes, the frequency of insulitis and thyroiditis was reduced in both the untreated blood and T cell depleted blood recipient. It should be noted, however, that the lowest frequencies were found in the untreated blood recipients. Insulitis was entirely absent in this group.
When the rats are grouped according to the presence of either insulitis or diabetes, the outcome of the experiment is clearer. Only 1 of 20 (5%) rats given untreated blood had either lesion, as compared with 11 of 20 (55%) rats given T cell depleted blood and 18 of 19 (95%) saline controls (P < 0.001).
Lymphocyte subsets. These results are shown in Table VI . White blood cell count was greater in the control rats than in either ofthe two experimental groups, but there was considerable variability and this difference was not significant. In general, both blood recipient groups had higher subset percentages than did the controls. This was true of both peripheral and splenic lymphocytes.
Con A induced lymphocyte stimulation. At all dosages of con A, the response of the rats transfused with untreated whole blood was statistically similar to that ofrats given T cell depleted (12) 5.5±1.0t (6) Number of rats is given in parentheses.
* Saline significantly less than other groups (P < 0.01). * Saline significantly less than other groups (P < 0.05).
blood, and the responses of both of these groups were greater than that of saline treated rats (Table VII) .
Discussion
These data confirm and extend our previous observation that blood transfusion prevents diabetes in susceptible BB/W rats. The first experiment demonstrates that white blood cells are the protective component oftransfused blood. Only five weekly transfusions were required for protection with white cells, as contrasted with the 11 transfusions of whole blood employed in our initial report (14) . In this experiment the erythrocyte concentrate may also have provided some degree of protection. This is most readily explained by contamination of the erythrocyte concentrate with a small number of white blood cells.
The white cell recipients in the second half of the experiment
were not sacrificed and have been protected from diabetes through 1 yr of age.
The postmortem studies show that the white blood cell concentrate not only protected against diabetes but also ameliorated other immunologic abnormalities frequently observed in the diabetes-prone animal. Insulitis, the pathologic substrate of autoimmune diabetes, was totally absent in white cell treated animals. Thyroiditis, another autoimmune abnormality frequently observed in the BB rat (20) , was also much reduced in animals receiving white cell concentrate.
Lymphocytopenia is also a characteristic immunologic abnormality of the BB rat (12, 23, 24, 25) . Although the total white blood cell count was not increased by transfusion, animals receiving white cell concentrate had a greatly increased percentage of OX 19 labeled circulating T lymphocytes. In particular, the percentage of W 3/25 helper cells was substantially higher, and there was some suggestion that the percentage of OX 8 suppressor/killer cells was also increased by white cell transfusion.
The results of the con A studies are consistent with previous observations (14) . Animals transfused with white cells displayed enhanced thymidine incorporation when compared with either plasma or saline treated animals. Again, a similar effect was also observed in those animals who received the erythrocyte concentrate.
The second set of experiments compared the degree of protection afforded by transfusion of spleen cells derived from W-line rats with that afforded by transfusion of spleen cells derived from nondiabetic but diabetes-prone BB/W rats. Again, nearly complete protection from diabetes was afforded by the transfusion of lymphocytes from W-line rats. Transfusion of lymphocytes from nondiabetic diabetes-prone BB/W rats was not at all protective.
The results of the first two experiments suggest that there is a defect in cellular immunity in the diabetes-prone BB/W rat which permits the development of diabetes mellitus and which is corrected by the transfusion of peripheral or splenic lymphocytes from diabetes-resistant rats. It might be argued that the effects that we have observed with transfusion are due to nonspecific allogeneic transfusion immunosuppression (26) . However, it should be noted that the BB/W rat is not yet inbred. Skin grafts from one BB/W line are rejected by recipients from another line, albeit slowly when the recipient is a diabetes-prone rat (unpublished observations). In experiment 2, the splenic lymphocytes from diabetes-prone BB/W rats were obtained from various lines and pooled. Thus both the W-line spleen cells and the diabetes-prone spleen cells constituted allogeneic transfusions, but only the W-line cells There were, however, no significant differences between the whole blood and the T cell depleted blood groups with respect to T cell subsets or con A responsiveness, and the responses of both ofthese groups were greater than those ofthe saline treated controls. These observations are consistent with those of the first experiment, in which rats transfused with erythrocyte concentrate were not protected from diabetes but exhibited some degree of immunologic restoration, as evidenced by enhanced con A responsiveness and a reduction in the frequency of both thyroiditis and anti-smooth muscle autoantibodies.
The most likely explanation for these observations is the presence of a small number of T The fact that the protective effect of transfusion lasts for more than a year may imply either that the transfused cells permanently altered the effector cell population of the diabetesprone rats at the time of transfusion or that progenitor T cells repopulated a deficient compartment in the recipients. The absence of markers able to detect chimers among these rats makes it impossible to select between these alternatives. The precise subset or number of T lymphocytes responsible for protection and the molecular mechanism by which such lymphocytes exert their effect remain to be determined.
We speculate that there exists a spectrum of immunodeficiency in BB 
